Erratum: Corrigendum to ‘Efficacy of a standard meticillin-resistant Staphylococcus aureus decolonisation protocol in routine clinical practice’ (Journal of Hospital Infection (2010) 75(2) (93–98) (S0195670109005301) (10.1016/j.jhin.2009.11.025));Efficacy of a standard meticillin-resistant Staphylococcus aureus decolonisation protocol in routine clinical practice

Journal of Hospital Infection

Volumn 75, Issue 2, 2010, Pages 93-98

  Gilpin, D F ^a   Small, S ^b   Bakkshi, S ^a   Kearney, M P ^b   Cardwell, C ^c   Tunney, M M ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b NORTHERN HEALTH AND SOCIAL CARE TRUST   (United Kingdom)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Chlorhexidine; Decolonisation; Meticillin resistant Staphylococcus aureus; Mupirocin; Pulsed field gel electrophoresis

Indexed keywords

CHLORHEXIDINE GLUCONATE; CX ANTISEPTIC DUSTING POWDER; PSEUDOMONIC ACID; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL DECOLONIZATION; BACTERIUM CULTURE; BACTERIUM ISOLATION; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG TREATMENT FAILURE; FEMALE; FOLLOW UP; HUMAN; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NONHUMAN; RISK FACTOR; SCREENING TEST; SENSITIVITY ANALYSIS; THROAT CULTURE; TREATMENT DURATION; ADOLESCENT; COHORT ANALYSIS; DRUG EFFECT; HETEROZYGOTE; INFANT; LONGITUDINAL STUDY; MIDDLE AGED; PRESCHOOL CHILD; PROSPECTIVE STUDY; STAPHYLOCOCCUS INFECTION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CARRIER STATE; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HUMANS; INFANT; LONGITUDINAL STUDIES; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77952580906     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2016.07.018     Document Type: Erratum

References (19)

1. Coia J.E., Duckworth G.J., Edwards D.I., et al. Guidelines for the control and prevention of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities. J Hosp Infect 2006, 63(Suppl. 1):S1-S44.
2. Davis K.A., Stewart J.J., Crouch H.K., Florez C.E., Hospenthal D.R. Methicillin-resistant Staphylococcus aureus (MRSA) nares colonization at hospital admission and its effect on subsequent MRSA infection. Clin Infect Dis 2004, 39:776-782.
3. Robicsek A., Beaumont J.L., Paule S.M., et al. Universal surveillance for methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals. Ann Intern Med 2008, 148:409-418.
4. Baldwin N.S., Gilpin D.F., Hughes C.M., et al. Prevalence of methicillin-resistant Staphylococcus aureus colonization in residents and staff in nursing homes in Northern Ireland. J Am Geriatr Soc 2009, 57:620-626.
5. Simor A.E., Daneman N. Staphylococcus aureus decolonization as a prevention strategy. Infect Dis Clin North Am 2009, 23:133-151.
6. Buehlmann M., Frei R., Fenner L., Dangel M., Fluckiger U., Widmer A.F. Highly effective regimen for decolonization of methicillin-resistant Staphylococcus aureus carriers. Infect Control Hosp Epidemiol 2008, 29:510-516.
7. McConeghy K.W., Mikolich D.J., LaPlante K.L. Agents for the decolonization of methicillin-resistant Staphylococcus aureus. Pharmacotherapy 2009, 29:263-280.
8. Loeb M., Main C., Walker-Dilks C., Eady A. Antimicrobial drugs for treating methicillin-resistant Staphylococcus aureus colonization. Cochrane Database Syst Rev 2003, (4):CD003340.
9. Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40:373-383.
10. Aldeyab M.A., Kearney M.P., Hughes C.M., et al. Can the use of a rapid polymerase chain screening method decrease the incidence of nosocomial meticillin-resistant Staphylococcus aureus?. J Hosp Infect 2009, 71:22-28.
11. Andrews J.M. BSAC standardized disc susceptibility testing method (version 7). J Antimicrob Chemother 2008, 62:256-278.
12. Robicsek A., Beaumont J.L., Thomson R.B., Govindarajan G., Peterson L.R. Topical therapy for methicillin-resistant Staphylococcus aureus colonization: impact on infection risk. Infect Control Hosp Epidemiol 2009, 30:623-632.
13. Kintarak S., Whawell S.A., Speight P.M., Packer S., Nair S.P. Internalization of Staphylococcus aureus by human keratinocytes. Infect Immun 2004, 72:5668-5675.
14. Simor A.E., Phillips E., McGeer A., et al. Randomized controlled trial of chlorhexidine gluconate for washing, intranasal mupirocin, and rifampin and doxycycline versus no treatment for the eradication of methicillin-resistant Staphylococcus aureus colonization. Clin Infect Dis 2007, 44:178-185.
15. Hurdle J.G., O'Neill A.J., Mody L., Chopra I., Bradley S.F. In vivo transfer of high-level mupirocin resistance from Staphylococcus epidermidis to methicillin-resistant Staphylococcus aureus associated with failure of mupirocin prophylaxis. J Antimicrob Chemother 2005, 56:1166-1168.
16. Rossney A., O'Connell S. Emerging high-level mupirocin resistance among MRSA isolates in Ireland. Euro Surveill 2008, 13(14).
17. Deshpande L.M., Fix A.M., Pfaller M.A., Jones R.N. Emerging elevated mupirocin resistance rates among staphylococcal isolates in the SENTRY Antimicrobial Surveillance Program (2000): correlations of results from disk diffusion, Etest and reference dilution methods. Diagn Microbiol Infect Dis 2002, 42:283-290.
18. Urth T., Juul G., Skov R., Schonheyder H.C. Spread of a methicillin-resistant Staphylococcus aureus ST80-IV clone in a Danish community. Infect Control Hosp Epidemiol 2005, 26:144-149.
19. Huijsdens X.W., van Santen-Verheuvel M.G., Spalburg E., et al. Multiple cases of familial transmission of community-acquired methicillin-resistant Staphylococcus aureus. J Clin Microbiol 2006, 44:2994-2996.